![[Pack of 2] Multi Collagen Supplements for Women - 10,000mg Type I, II, III, V & X Hydrolysed Marine Collagen Powder, Bovine Collagen, Egg & Cartilage Collagen Peptides for Skin, Hair, Nails & Joints](https://m.media-amazon.com/images/I/61yBhnLdFNL._AC_SY145_.jpg)
结论很明确:这个市场不值得进入,已经是高压价格战市场,对大品牌和小商家都不友好。 新品牌一共13个,但新品牌新上架成功率是0%,18个新上架里没有一个跑出可验证盈利;同时近期入场的产品利润几乎都卡在0%~10%,说明不是还有空间,而是利润被压到很薄。
These products have successfully captured market share and are profitable. Their design and features are suggested for your investment, based on market competition, saturation, and demand.
Green indicates better success rate, red indicates poorer success rate. If you are a new brand, focus on the left side; if you are an old brand, focus on the right side.
结论很直接:这个市场不值得进入,用户预算够做单个ASIN的首发,但不够撑起真正有效的竞争;更重要的是,市场已经明显陷入价格战,连新品牌都几乎没有盈利空间。 500000 CNY 只能覆盖入场前几个月的备货、物流和推广,不含研发、品牌和认证,按现在的数据看,进去也很难赚到钱。
Alternative solutions may pose a risk to your investment in certain markets.
这个市场不适合进入,且对新品牌已经接近价格战/饱和区。 现有数据里,市场整体可盈利产品只占11.11%,而新上架产品盈利率为0%;同时,新品牌新上架里已经出现多家新入场者,且几乎全部都没跑通,说明不是“还有机会”,而是“进场就被压利润”。
证据很明确:新品牌代表 ZyranovaE 的新ASIN B0G814P3RT 只能做到9.31%利润率,已经低于你要求的可接受线;另一个新品牌 NVXNMSD 的新ASIN B0GTQL3FLN 只有6.43%利润率且销量未跑起来。 这两个新品牌都不是成功样本,反而说明新入场需要面对很低的利润空间和启动失败风险。市场里还看到老品牌 Revive Naturals 的成功ASIN B07GJ66C1C,利润率12.76%,月销2000,月营收约40660英镑,累计早期投入约62668.29美元;但它的另一个老品 B084YY2KXB 只有10.44%,B07ZHGWCTR 甚至只有7.28%,说明连老品牌都在被利润压缩。你要复制的不是“老品牌身份”,而是它的产品组合:五种胶原类型 + 易溶 + 无腥味 + 复合功能诉求;但注意,Revive Naturals 这种打法属于成熟资源型打法,不是小商家可直接照搬的低成本路径。
小商家结论更直接:没有真正可抄的低门槛成功案例。 数据里没有出现<300评价、且利润率和销量都同时成立的“真实小商家胜出”样本;相反,B0GTQL3FLN 只有11个评价、销量没起来,属于失败样本而不是案例。大品牌可参考 Revive Naturals 的 B07GJ66C1C,复制其“高复合配方+高客单+成熟内容”定位;小商家应直接放弃这个细分,因为当前市场已经表现出新品牌成功率为0、整体盈利率仅11.11%、新品牌新上架全军覆没。如果你硬要进场,至少需要接近 50万 CNY 级别预算去承担前期铺货、广告和试错,但这仍然不保证能突破价格战。
这不是一个适合进入的市场:利润率整体偏低、竞争已进入明显价格战,且新品牌几乎没有可验证的成功案例。 以当前数据看,市场对大品牌和小生意都不友好,尤其不适合在没有强品牌力或重研发投入的情况下贸然进入。
市场里一共只看到29个品牌,但新品牌已经有13个,接近一半;更关键的是,新产品中只有38.89%落在0%~10%利润区间,10%~20%仅11.11%,而高于20%的新产品为0。换句话说,新进入者几乎都卡在低利润带里,像 B0G814P3RT(ZyranovaE,18.13 GBP)和 B0G3X7Q1G7(Yin & Yang Superfoods,15.66 GBP)都没过盈利线,B0GTQL3FLN(NVXNMSD,17.49 GBP)甚至是负利润。新品牌新上架盈利率为0%,失败率100%;老品牌的新上架也没有任何盈利案例。这个信号非常直接:市场不是“还能拼一下”,而是已经被挤到只剩少数老品牌和强投放玩家能活。
对大品牌来说,能跟的样板主要是 Revive Naturals 的 B07GJ66C1C(约£20.33,月销2000,月利润约£5188)和 ALPHA01 的 B084YQW9DN(约£9.99,月销3000,月利润约£3135),但它们都属于老品牌打法,靠的是品牌力+成熟老款,不是新品牌轻资产能复制的路径。对小生意来说,可作为“真实成功案例”的只有极少数,而且这组数据里几乎找不到<300评论/年还能稳定盈利的新品牌样板;相反,像 B0FBX7636G(Warrior,323评论)这种已接近高压投放/强品牌打法的产品,仍然只能算低利润甚至亏损边缘。再加上成功产品普遍依赖老款延伸、配方堆叠、品牌积累,说明要做出可观利润,通常还需要额外的研发、认证和品牌预算,这已经超出单一ASIN的启动成本逻辑。结论很清楚:不要进。 如果一定要做,只能把它当作大品牌重投放项目;小生意没有不靠激进营销也能稳定赢的空间。
All products profit ratio distribution, including all products. For products with insufficient sales or missing profit ratio data, they will be categorized into other rows. This distribution included products that cannot determine the release date.
This are the profit ratios of all new products. There are products without sufficient sales, no more than 100pcs in 3 months, or no profit ratio data, or just released. Those will be considered as 'other'
Most profitable products ranked by profit value. Only includes products with positive profitability and active sales, regardless of release date.
![]() | B07GJ66C1C | Revive Naturals | 2018-10-21 | Yes | £20.33 | 2000pcs | £40660.0 | 12.76% | £5188.22 |
![]() | B08P26Q7Y5 | The Intelligent Health | 2020-11-23 | Yes | £15.97 | 2000pcs | £31940.0 | 11.25% | £3593.25 |
![]() | B084YQW9DN | ALPHA01 | 2018-10-21 | Yes | £9.99 | 3000pcs | £29970.0 | 10.46% | £3134.87 |
![]() | B084YY2KXB | Revive Naturals | 2018-10-21 | Yes | £14.78 | 2000pcs | £29560.0 | 10.44% | £3086.07 |
![]() | B0CCZLNV35 | ONYX INGREDIENTS 101 | 2023-06-08 | Yes | £19.99 | 50pcs | £999.5 | 13.75% | £137.44 |
![]() | B0CVQBFBG9 | Feel Complete | 2024-02-12 | Yes | £14.99 | 50pcs | £749.5 | 10.5% | £78.7 |
New products with negative profitability ranked by lowest profit value. Only includes newly released products classified as non-profitable.
![]() | B0G3X7Q1G7 | Yin & Yang Superfoods | 2025-11-25 | No | £15.66 | 50pcs | £783.0 | 4.85% | £37.98 |
![]() | B0G3XGVNQQ | REFINED NUTRITION | 2025-12-08 | No | £16.99 | 30pcs | £509.7 | 8.49% | £43.28 |
![]() | B0G2KB73B6 | Shrimp Nature | 2025-11-16 | No | £16.78 | 50pcs | £839.0 | 5.82% | £48.83 |
![]() | B0G2H3YZ7Q | chenyayun | 2025-11-15 | No | £17.63 | 50pcs | £881.5 | 7.74% | £68.23 |
![]() | B0GFX1BMG6 | 4 | 2026-02-27 | No | £17.82 | 200pcs | £3564.0 | 7.73% | £275.5 |
![]() | B0G39SQ2XZ | GMOLARSUSCO | 2025-12-29 | No | £17.48 | 200pcs | £3496.0 | 8.93% | £312.2 |
![]() | B0G814P3RT | ZyranovaE | 2025-12-17 | No | £18.13 | 200pcs | £3626.0 | 9.31% | £337.59 |
![]() | B0GTQL3FLN | NVXNMSD | 2026-03-24 | No | £17.49 | -pcs | £- | 6.43% | £- |
![]() | B0GL3F4T17 | Vitavea | 2026-02-02 | No | £15.68 | -pcs | £- | 9.02% | £- |
![]() | B0GY9QLFMX | Roam & Ritual | 2026-04-23 | No | £9.85 | -pcs | £- | -5.58% | £- |
![]() | B0GCTXQ6Z1 | welzo | 2025-12-27 | No | £23.22 | -pcs | £- | 12.22% | £- |
![]() | B0GS6L71SL | TailaiMei | 2026-03-11 | No | £18.99 | -pcs | £- | 5.98% | £- |
![]() | B0G266ZR7Q | Amaana Wellness | 2025-11-13 | No | £14.99 | -pcs | £- | 10.31% | £- |
![]() | B0G72HZH1N | Yin & Yang Superfoods | 2025-12-15 | No | £- | -pcs | £- | -% | £- |
![]() | B0H3KRTLS4 | Freak Athletics | 2026-06-01 | No | £- | -pcs | £- | -% | £- |
![]() | B0H2Q8TWFR | welzo | 2026-05-23 | No | £- | -pcs | £- | -% | £- |
![]() | B0GNVN3T4L | Amaana Wellness | 2026-02-17 | No | £- | -pcs | £- | -% | £- |
![]() | B0FKV9SBBY | ONYX INGREDIENTS 101 | 2025-08-01 | No | £- | -pcs | £- | -% | £- |
这个市场不值得进入,已经接近价格战+过度拥挤的状态。 关键不是“有没有人成功”,而是新品牌几乎全军覆没:新品牌新上架的成功率是0%,整体可识别产品里只有11.11%盈利,说明大多数产品都在低利润甚至亏损区间里打转。
What is the ratio of profitable products
What is the ratio of different brands owning all nonprofitable new products
这个市场已经不适合进入:新品牌几乎全军覆没,最近一批新上架产品里 16 个全部不盈利,盈利率 0%,而且近两年新增节奏并没有放缓,反而持续有新品牌涌入,典型的高竞争、低回报市场。 对大品牌和小商家都不是好机会;小商家更没有可复制的真实成功样本,反而更像是被价格战和营销战挤压。
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Y-axis is product counts. X-axis is time period. For each time period, there are 2 column, each column is a released type of a product. Columns are in following orders: New product, New product on old listing
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2022 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2023 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2024 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 6 | 0 | 0 | 0 | 0 | 4 |
| 2026 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 7 |
Header is the profit ratios and first column is different time period. Each cells includes how many products are relased at the specific timerange and has a corresponding profit ratios. Only profitable and with active sales (more than 100 pcs in 3 months) will be considered. Any products without sufficient sold units in 3 months will be marked as 'other'.
| Time/Profit% | x < -10.0% | -10.0% <= x < 0.0% | 0.0% <= x < 10.0% | 10.0% <= x < 20.0% | 20.0% <= x < 30.0% | 30.0% <= x < 40.0% | x >= 40.0% | other |
|---|---|---|---|---|---|---|---|---|
| 2025/7 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/8 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2025/9 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025/11 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 1 |
| 2025/12 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 2 |
| 2026/1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2026/2 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 2 |
| 2026/3 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 |
| 2026/4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/5 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |
| 2026/6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 |